BRAINLIFE Brain Tumor Medical Database

Immunotherapy

Home > Database > Treatment > Immunotherapy

Contents



Choroid Plexus Tumors


Timothy J, Chumas P, Chakrabarty A, Drake JM, Morrison E
Destruction of choroid plexus cells in vitro: a new concept for the treatment of hydrocephalus
Neurosurgery. 2004 Mar;54(3):727-32


Medulloblastoma


Peter A Forsyth, Wen Qing Yang, Donna Senger, Huong Muzik, Zhong Q Shi, Penny Brasher, Richard Dyck
Reovirus oncolysis in medulloblastoma is effective in vivo and safe in rodents and primates
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. Abstract No. 289



Neuroblastoma


A. Batova, A. L. Yu, D. Strother, P. Angelini, A. Eskenazi
Promising results of a pilot trial of a GD2 directed anti-idiotypic antibody as a vaccine for high risk neuroblastoma
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8511

Joshi AD, Clark EM, Wang P, Munger CM, Hegde GV, Sanderson S, Dave HP, Joshi SS
Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cells
J Neuroimmune Pharmacol. 2007 Jun;2(2):202-12. Epub 2006 Oct 11
Abstract

Tahira Khan, Julie A. Hixon, Jimmy K. Stauffer, Erin Lincoln, Timothy C. Back, Jason Brenner, Stephen Lockett, Kunio Nagashima, Douglas Powell, Jon M. Wigginton
Therapeutic Modulation of Akt Activity and Antitumor Efficacy of Interleukin-12 Against Orthotopic Murine Neuroblastoma
Journal of the National Cancer Institute, Vol. 98, No. 3, 190-202, February 1, 2006
  Abstract |   News

Mario Otto, Raymond C. Barfield, William J. Martin, Rekha Iyengar, Wing Leung, Thasia Leimig, Stanley Chaleff, Stephen D. Gillies and Rupert Handgretinger
Combination Immunotherapy with Clinical-Scale Enriched Human γδ T cells, hu14.18 Antibody, and the Immunocytokine Fc-IL7 in Disseminated Neuroblastoma
Clinical Cancer Research Vol. 11, 8486-8491, December 1, 2005
  Abstract |   News


Non-CNS Tumors


Batliwalla FM, Bateman BA, Serrano D, Murray D, Macphail S, Maino VC, Ansel JC, Gregersen PK, Armstrong CA
A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire
Mol Med 1998 Dec;4(12):783-94

Csatary LK, Eckhardt S, Bukosza I, Czegledi F, Fenyvesi C, Gergely P, Bodey B, Csatary CM
Attenuated veterinary virus vaccine for the treatment of cancer
Cancer Detect Prev 1993;17(6):619-27

Grant SC, Kris MG, Houghton AN, Chapman PB
Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guerin
Clin Cancer Res 1999 Jun;5(6):1319-23

Pecora AL, Rizvi N, Cohen GI, Meropol NJ, Sterman D, Marshall JL, Goldberg S, Gross P, O'Neil JD, Groene WS, Roberts MS, Rabin H, Bamat MK, Lorence RM
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
J Clin Oncol 2002 May 1;20(9):2251-66


This website is certified by Health On the Net Foundation. Click to verify. HOMEARCHIVES OF NEURO-ONCOLOGYCURRENT NEURO-ONCOLOGYGLIOBLASTOMA REPORTS
SERVICES: About BrainLife | Brain Tumor Medical Database | Children's Corner | Dedication | E-mail Alerts | Journals | Privacy Policy | Publications

This site complies with the HONcode standard for trustworthy health information: verify here bottom